Allchem Lifesciences IPO

Upcoming Mainboard

Already have an account? Apply now

Allchem Lifesciences IPO details

To be announced
–
–
–

View all IPOs →

About Allchem Lifesciences

Founded in 2003 by Mr. Bipin Patel, Allchem Lifescience is a manufacturer of API intermediates and specialty chemicals. The company serves pharmaceutical, agrochemical, and industrial clients. Headquartered in Vadodara, Gujarat, it operates an ISO-certified facility. Allchem Lifescience has established relationships in over 20 countries. The company focuses on innovation, quality, and sustainability, supported by R&D and regulatory compliance.

Financials of Allchem Lifesciences

*All figures are in ₹ Crores.

Issue size

Funds Raised in the IPO Amount
Overall –
Fresh Issue  ₹190 crores
Offer for sale ₹ 7.15 crores

Utilisation of proceeds

Purpose INR crores (%)
Repayment of outstanding borrowings 130 (68.42%)
General corporate purposes (not above 25% of gross proceeds)

Strengths

  • Established customer relationships ensure consistent business stability.
  • Diversified exports broaden global market reach and credibility.  
  • Sustainable manufacturing in a well-equipped facility. 
  • Strong R&D drives innovation in industrial chemistries.  
  • Experienced leadership fuels financial growth and consistency.

Risks

  • Over 90% of revenue depends on pharmaceutical industry demand.
  • Top 10 customers contribute over half of revenue. 
  • Promoters involved in pending NDPS-related legal proceedings.  
  • No long-term contracts with key raw material vendors.  
  • Working capital cycle stretched; inventory turnover significantly declined.